DK435384A - L-argininisoxicamat - Google Patents

L-argininisoxicamat Download PDF

Info

Publication number
DK435384A
DK435384A DK435384A DK435384A DK435384A DK 435384 A DK435384 A DK 435384A DK 435384 A DK435384 A DK 435384A DK 435384 A DK435384 A DK 435384A DK 435384 A DK435384 A DK 435384A
Authority
DK
Denmark
Prior art keywords
argininisoxicamat
compound
disclosed
processes
producing
Prior art date
Application number
DK435384A
Other languages
English (en)
Other versions
DK435384D0 (da
Inventor
Lester Chafetz
Wen-Hai Hong
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK435384D0 publication Critical patent/DK435384D0/da
Publication of DK435384A publication Critical patent/DK435384A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/06Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/46Phenazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/34[b, e]-condensed with two six-membered rings with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/36[b, e]-condensed, at least one with a further condensed benzene ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK435384A 1983-09-28 1984-09-12 L-argininisoxicamat DK435384A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53648183A 1983-09-28 1983-09-28

Publications (2)

Publication Number Publication Date
DK435384D0 DK435384D0 (da) 1984-09-12
DK435384A true DK435384A (da) 1985-03-29

Family

ID=24138678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK435384A DK435384A (da) 1983-09-28 1984-09-12 L-argininisoxicamat

Country Status (13)

Country Link
EP (1) EP0140492B1 (da)
JP (1) JPS6072890A (da)
AT (1) ATE39925T1 (da)
AU (1) AU557394B2 (da)
CA (1) CA1213888A (da)
DE (1) DE3476065D1 (da)
DK (1) DK435384A (da)
ES (1) ES8606259A1 (da)
GR (1) GR80337B (da)
IL (1) IL71989A (da)
NZ (1) NZ209701A (da)
PH (1) PH20151A (da)
ZA (1) ZA845244B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83109A (en) * 1986-07-11 1992-06-21 Ciba Geigy Ag Guanidinium aspartates,their preparation and pharmaceutical compositions containing them
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
EP1455774B1 (en) * 2001-11-26 2006-03-01 Lean-Ex Ltd. Pharmaceutical composition for treating obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts

Also Published As

Publication number Publication date
DE3476065D1 (en) 1989-02-16
ATE39925T1 (de) 1989-01-15
ZA845244B (en) 1985-02-27
EP0140492B1 (en) 1989-01-11
AU3003484A (en) 1985-04-04
CA1213888A (en) 1986-11-12
EP0140492A1 (en) 1985-05-08
IL71989A0 (en) 1984-10-31
JPS6072890A (ja) 1985-04-24
IL71989A (en) 1987-10-30
DK435384D0 (da) 1984-09-12
GR80337B (en) 1985-01-14
ES535408A0 (es) 1986-04-01
ES8606259A1 (es) 1986-04-01
PH20151A (en) 1986-10-08
NZ209701A (en) 1986-12-05
AU557394B2 (en) 1986-12-18

Similar Documents

Publication Publication Date Title
NO831679L (no) Fremgangsmaate for fremstilling av farmakologisk aktive 1,3-dioksan-5-yl-alkensyrer
NO159291C (no) Fremgangsmaate for fremstilling av gamma-substituerte 3(r)-hydroxysmoersyrederivater.
IT1172398B (it) Procedimento per la produzione di 1,2-diclorcetano
ATE39925T1 (de) L-arginin-isoxicamat.
NO157099C (no) FremgangsmŸte for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater.
FI862336A0 (fi) Nytt foerfarande foer framstaellning av 7-aca-derivat.
IT8422145A0 (it) Procedimento per la produzione di beta-fenilserina.
PT86611A (pt) Process for the manufacture of n,n-(dibenzohexatrienylene)ureas
TR23271A (tr) En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
FI861490A0 (fi) Komposition foer framstaellning av kartongbehaollare foer vaetskor.
FI833501A0 (fi) Foerfarande foer framstaellning av 15-cykloalifatiska haerledningar av 13,14-didehydro-karboprostacykliner
IT1176093B (it) Procedimento per la produzione di composizioni elastromere termoplastiche
IT1164613B (it) Procedimento per la produzione di ditiazol-disolfuri
NO871721D0 (no) Fremgangsmaate for fremstilling av ergolenderivater.
TR21803A (tr) Atese dayanikh krommagnezi ueruenlerinin ueretilmesine mahsus usul
IT8420608A0 (it) Procedimento per la produzione di s-carbossimetilcisteina.
IT8224069A0 (it) Talampicillina. procedimento per la produzione di
IT1151184B (it) Procedimento per la sintesi di 2,4,6 trimetil-4 idrossicicloesa-2,5 dien-1 one
IT8324024A1 (it) Procedimento per la produzione di polifenilenossido
TR24378A (tr) N-aril,3-aril,4,5 dikodro,1 h-pirazol 1-karboksa- midler bunlarin ueretimine mahs
IT8224137A0 (it) Procedimento migliorativo per laproduzione di pentamicina.
IT1125431B (it) Procedimento per la produzione di 2,6-dinitro-n-alchil-aniline
IT8320984A0 (it) Procedimento per la realizzazione di un elemento scatolare attrezzato, nonche' elemento scatolare cosi' ottenuto.
ES523125A0 (es) "procedimiento de producir derivados de n-fosfonometilglicina".

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment